A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 1358894 once daily over 12 week treatment period in patients with borderline personality disorder.

Chen, L. Y. & De Castella, A.

1/12/20 → 31/12/23

Project: Research

A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily with adjunctive Computerized Cognitive Training over 12 week treatment periods in patients with schizophrenia.

Chen, L. Y. & De Castella, A.

1/12/20 → 31/12/23

Project: Research

Sarah Kelly Jones Program

De Castella, A. & Kulkarni, J.

27/10/20 → 31/12/23

Project: Research

A Phase II, 6-week, multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel group trial with a quetiapine arm to evaluate the efficacy, tolerability and safety of oral BI 1358894 in patients with Major Depressive Disorder with inadequate response to antidepressants.

Chen, L. Y. & De Castella, A.

6/10/20 → 31/12/24

Project: Research

The Damian Project

Kulkarni, J., Gurvich, C., De Castella, A. & Thomas, N.

The Mohr Family

1/07/19 → 30/06/28

Project: Research